Editorial Staff

Amar Sawhney on Sikhs, STEM & COVID

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

The entrepreneurial spirit among immigrants and refugees allows them the flexibility to pursue unexpected courses of action, adapt, accept risk and make the most of opportunities they didn’t even know of before. For Dr. Amar Sawhney from India, that started at the University of Texas at Austin with 30 job rejections out of 30 applications. But he charted a path that would see him go in directions hitherto unknown to him: getting a PhD, helping found a company, journeying to Boston, and starting a string of new companies, using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue. He’s been named a “Champion of Change” by The White House, one of the “five most innovative Medical Device CEOs” by MassDevice, the EY regional entrepreneur of the year, The Immigrant Learning Center’s own Immigrant Entrepreneur Awardee for Life Science Business. But his influence extends well beyond that space into environmental conservationism, safeguarding refugees, mentoring and promoting STEM education, and building public understanding of America’s Sikhs, as you’ll hear in this week’s episode of JobMakers.

Guest:

Amarpreet Sawhney, Ph.D., is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions. Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc. (acquired by Boston Scientific), Founder and CEO of Confluent Surgical (acquired by Covidien), the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. (acquired by Cardinal Health). He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of EcoSikh, Axtria, Imperative care, Instylla, Rejoni, Tulavi, and Incept LLC. He is on the advisory board of the MIT museum. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

Get new episodes of JobMakers in your inbox!

Browse recent episodes of Pioneer podcasts:

Tufts Prof. Elizabeth Setren on METCO’s Proven Results

Prof. Setren discusses her recent study of METCO, a pioneering voluntary school desegregation program under which Massachusetts students in Boston and Springfield are bused to surrounding suburban districts. She discusses METCO's history, the academic performance of students in the program, enrollment challenges, long-term benefits, and disparities among students.

Biden’s Budget Breakdown: Pragmatic Progress or Political Posturing

Joe Selvaggi talks with Manhattan Institute Senior Fellow Brian Reidl about how the contours of President Biden’s recently released budget proposal reveal a persistent, bipartisan reluctance to address profound structural deficits.

Pulitzer Winner Joan Hedrick on Harriet Beecher Stowe & Uncle Tom’s Cabin

Prof. Hedrick discusses Harriet Beecher Stowe's wide literary influence on U.S. history. From her abolitionist activism to the publication of international bestseller Uncle Tom's Cabin, they explore Stowe's New England upbringing, anti-slavery convictions, and lasting impact on American literature and social reform in the 19th century.

Genetic Therapy Revolution: Benefits and Barriers for Medicine’s New Horizon

Joe Selvaggi talks with neurobiologist and writer Dr. Anne Sydor about the potential for gene therapy to address deadly and debilitating diseases and how current health care models must adapt to encourage this nascent technology.

Dr. Adrian Mims on The Calculus Project & STEM

Dr. Mims navigates through the contentious "math wars" and underscores the pivotal role of Algebra I as a gateway to higher math. He also evaluates the negative impact of Common Core math standards, and proposes strategies to combat pandemic-induced learning setbacks and bridge the gap in math proficiency between American students and their international counterparts.

Contours of Content Curation: SCOTUS Hears Online Free Speech Cases

Cato Institute's Thomas Berry, talks about oral arguments at the Supreme Court in the NetChoice cases, exploring the First Amendment questions that affect both social media users and the platforms that curate their content.

Yale University Pulitzer Winner Beverly Gage on J. Edgar Hoover & the FBI

Yale Prof. Beverly Gage, author of "G-Man: J. Edgar Hoover and the Making of the American," delves into the enigmatic life and career of J. Edgar Hoover, tracing his formative years in Washington, D.C., his rise to prominence as director of the FBI, and his enduring influence on American law enforcement and politics.

Mortgage’s New Normal: Guide to Better Borrowing Amidst Higher Rates

Joe Selvaggi talks with mortgage expert, Trip Miller of Cambridge Savings Bank, about mortgage rates and trends and explores best practices for finding a mortgage structure that suits individual buyers’ needs.

UK U-Warwick’s Benjamin Smith on Mexico’s Cartels & Drug Trade

Prof. Benjamin Smith, author of The Dope: The Real History of the Mexican Drug Trade, provides insights into various aspects of the Mexican drug trade, including its historical context and the evolution of illicit drug products over time. He discusses key cartels and their methods, the impact of the drug trade on Mexico's murder rates, the immense financial scale of the trade, its effect on Mexico and the U.S., and the challenges law enforcement face in combating it. Smith explores the relationship among Mexican cartels, other foreign countries, and the illicit drug market in the U.S.

Medicaid’s Massive Miasma: Taming Beacon Hill’s Burgeoning Budget Beast

Marc Joffe, a state policy analyst at the Cato Institute, talks about his research on Medicaid's cost and size. They explore how Massachusetts can control spending growth while protecting other priorities.

DFER-MA’s Mary Tamer on MCAS & Teacher Strikes

Mary Tamer focuses on the historic impact of the 1993 Massachusetts Education Reform Act on the commonwealth’s students’ high achievement on national and international measures. She explores the politics of the Massachusetts Teachers Association advocating against the MCAS test as a graduation requirement. In closing, Ms. Tamer also discusses the rise of teacher strikes and their implications for education reform in the Bay State.

Baystate Budget Blues: Declining Revenue Causes Concern

Joe Selvaggi engages in a conversation with Pioneer Institute’s Eileen McAnneny, Senior Fellow for Economic Opportunity, to analyze the status of the 2024 budget. They compare actual revenue and spending with pre-July 1 estimates, investigating potential reasons for any surpluses or shortfalls. They also dive into policy implications for legislators as they approach fiscal 2025.